PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LABD vs. SPXU
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


LABDSPXU
YTD Return-46.99%-46.87%
1Y Return-79.65%-59.39%
3Y Return (Ann)-34.58%-28.90%
5Y Return (Ann)-57.17%-46.89%
Sharpe Ratio-0.96-1.59
Sortino Ratio-1.87-2.90
Omega Ratio0.790.69
Calmar Ratio-0.77-0.58
Martin Ratio-1.14-1.43
Ulcer Index67.45%40.92%
Daily Std Dev80.00%36.72%
Max Drawdown-99.97%-99.98%
Current Drawdown-99.97%-99.98%

Correlation

-0.50.00.51.00.6

The correlation between LABD and SPXU is 0.57, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

LABD vs. SPXU - Performance Comparison

The year-to-date returns for both investments are quite close, with LABD having a -46.99% return and SPXU slightly higher at -46.87%. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%JuneJulyAugustSeptemberOctoberNovember
-36.36%
-32.46%
LABD
SPXU

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


LABD vs. SPXU - Expense Ratio Comparison

LABD has a 1.06% expense ratio, which is higher than SPXU's 0.93% expense ratio.


LABD
Direxion Daily S&P Biotech Bear 3x Shares
Expense ratio chart for LABD: current value at 1.06% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.06%
Expense ratio chart for SPXU: current value at 0.93% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.93%

Risk-Adjusted Performance

LABD vs. SPXU - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and ProShares UltraPro Short S&P500 (SPXU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LABD
Sharpe ratio
The chart of Sharpe ratio for LABD, currently valued at -0.96, compared to the broader market-2.000.002.004.006.00-0.96
Sortino ratio
The chart of Sortino ratio for LABD, currently valued at -1.87, compared to the broader market0.005.0010.00-1.87
Omega ratio
The chart of Omega ratio for LABD, currently valued at 0.79, compared to the broader market1.001.502.002.503.000.79
Calmar ratio
The chart of Calmar ratio for LABD, currently valued at -0.77, compared to the broader market0.005.0010.0015.00-0.77
Martin ratio
The chart of Martin ratio for LABD, currently valued at -1.14, compared to the broader market0.0020.0040.0060.0080.00100.00120.00-1.14
SPXU
Sharpe ratio
The chart of Sharpe ratio for SPXU, currently valued at -1.59, compared to the broader market-2.000.002.004.006.00-1.59
Sortino ratio
The chart of Sortino ratio for SPXU, currently valued at -2.90, compared to the broader market0.005.0010.00-2.90
Omega ratio
The chart of Omega ratio for SPXU, currently valued at 0.69, compared to the broader market1.001.502.002.503.000.69
Calmar ratio
The chart of Calmar ratio for SPXU, currently valued at -0.59, compared to the broader market0.005.0010.0015.00-0.59
Martin ratio
The chart of Martin ratio for SPXU, currently valued at -1.43, compared to the broader market0.0020.0040.0060.0080.00100.00120.00-1.43

LABD vs. SPXU - Sharpe Ratio Comparison

The current LABD Sharpe Ratio is -0.96, which is higher than the SPXU Sharpe Ratio of -1.59. The chart below compares the historical Sharpe Ratios of LABD and SPXU, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.50JuneJulyAugustSeptemberOctoberNovember
-0.96
-1.59
LABD
SPXU

Dividends

LABD vs. SPXU - Dividend Comparison

LABD's dividend yield for the trailing twelve months is around 5.98%, less than SPXU's 11.93% yield.


TTM2023202220212020201920182017
LABD
Direxion Daily S&P Biotech Bear 3x Shares
5.98%6.14%0.53%0.00%3.96%1.75%0.80%0.00%
SPXU
ProShares UltraPro Short S&P500
11.93%7.07%0.39%0.00%0.71%2.14%1.41%0.11%

Drawdowns

LABD vs. SPXU - Drawdown Comparison

The maximum LABD drawdown since its inception was -99.97%, roughly equal to the maximum SPXU drawdown of -99.98%. Use the drawdown chart below to compare losses from any high point for LABD and SPXU. For additional features, visit the drawdowns tool.


-100.00%-99.80%-99.60%-99.40%-99.20%JuneJulyAugustSeptemberOctoberNovember
-99.97%
-99.45%
LABD
SPXU

Volatility

LABD vs. SPXU - Volatility Comparison

Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 15.91% compared to ProShares UltraPro Short S&P500 (SPXU) at 12.02%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than SPXU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember
15.91%
12.02%
LABD
SPXU